Subscribe to RSS
DOI: 10.1055/s-2002-35788
Beeinflusst Rauchen den Verlauf der Colitis ulcerosa?
Publication History
Publication Date:
28 November 2002 (online)

Frage: In einer Studie wird erneut von einer statistisch positiven Korrelation zwischen Zigarettenrauchen und Besserung und bei Einstellen des Rauchens von einer Verschlechterung der Colitis ulcerosa berichtet.
Gibt es Erklärungen dazu, etwa in dem Sinne, dass dem Nikotin (allein?) dieser Effekt zuzuschreiben ist, und ggfs. Therapiestudien-Ergebnisse mit Nikotin (etwa als Pflaster) bei Colitis ulcerosa?
Soll man also ggfs. Colitis-ulcerosa-Patienten zum Rauchen oder - wohl weniger oder vielleicht gar nicht gesundheitsschädlich - zur Verwendung von Nikotinpflastern, und ggfs. in welcher Dosierung und Dauer, raten?
Literatur
- 1
Somerville K W, Logan R F, Edmond M, Langman M J.
Smoking
and Crohn’s disease.
Br Med J.
1984;
289
954-956
MissingFormLabel
- 2
Harries A D, Baird A, Rhodes J.
Non-smoking:
a feature of ulcerative colitis.
Br Med J.
1982;
284
706
MissingFormLabel
- 3
Malchow H.
Nikotin
und Colitis ulcerosa.
Dtsch Med Wochenschr.
1987;
112
1476
MissingFormLabel
- 4
Thomas G A, Rhodes J, Green J T.
Inflammatory
bowel disease and smoking - a review.
Am J Gastroenterol.
1998;
93
144-149
MissingFormLabel
- 5
Sandborn W J.
Nicotine
therapy for ulcerative colitis: a review of rationale, mechanisms,
pharmacology, and clinical results.
Am J Gastroenterol.
1999;
94
1161-1171
MissingFormLabel
- 6
Bridger S, Lee J C, Bjarnason I, Jones J E, Macpherson A J.
In siblings with similar genetic susceptibility
for inflammatory bowel disease, smokers tend to develop Crohn’s
disease and non-smokers develop ulcerative colitis.
Gut.
2002;
51
21-25
MissingFormLabel
- 7
Van Erpecum K J, Smits S J, van de Meeberg P C, Linn F H, Wolfhagen F H, van Berge-Henegouwen G P, Algra A.
Risk
of primary sclerosing cholangitis is associated with nonsmoking
behavior.
Gastroenterology.
1996;
110
1503-1506
MissingFormLabel
- 8
Loftus E V
Jr, Sandborn W J, Tremaine W J, Mahoney D W, Zinsmeister A R, Offord K P, Melton L J.
Primary
sclerosing cholangitis is associated with nonsmoking: a case- con-trol
study.
Gastroenterology.
1996;
110
1496-1502
MissingFormLabel
- 9
Angulo P, Bharucha A E, Jorgensen R A, DeSotel C K, Sandborn W J, Larusso N F, Lindor K D.
Oral nicotine
in treatment of primary sclerosing cholangitis: a pilot study.
Dig
Dis Sci.
1999;
44
602-607
MissingFormLabel
- 10
Vleggaar F P, van Buuren H R, van Berge
Henegouwen G P, Hop W C, van Erpecum K J.
No beneficial
effects of transdermal nicotine in patients with primary sclerosing
cholangitis: results of a randomized double-blind placebo-controlled
cross-over study.
Eur J Gastroenterol Hepatol.
2001;
13
171-175
MissingFormLabel
- 11
Jick H, Walker A M.
Cigarette smoking
and ulcerative colitis.
N Engl J Med.
1983;
308
261-263
MissingFormLabel
- 12
Odes H S, Fich A, Reif S, Halak A, Lavy A, Keter D, Eliakim R, Paz J, Broide E, Niv Y, Ron Y, Villa Y, Arber N, Gilat T.
Effects
of current cigarette smoking on clinical course of Crohn’s
disease and ulcerative colitis.
Dig Dis Sci.
2001;
46
1717-1721
MissingFormLabel
- 13
Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre J P, Cosnes J.
Impact of cessation of smoking
on the course of ulcerative colitis.
Am J Gastroenterol.
2001;
96
2113-2116
MissingFormLabel
- 14
Holt P G.
Immune
and inflammatory function in cigarette smokers.
Thorax.
1987;
42
241-249
MissingFormLabel
- 15
Ginns L C, Miller L G, Goldenheim P D, Goldstein G, Bria W F.
Alterations in immunoregulatory
cells in lung cancer and smoking.
J Clin Immunol.
1982;
2
90S-94S
MissingFormLabel
- 16
Madretsma G S, Donze G J, van Dijk A P, Tak C J, Wilson J H, Zijlstra F J.
Nicotine
inhibits the in vitro production of interleukin 2 and tumour necrosis
factor-a by human mononuclear cells.
Immunopharmacology.
1996;
35
47-51
MissingFormLabel
- 17
Madretsma S, Wolters L M, van Dijk J P, Tak C J, Feyerabend C, Wilson J H, Zijlstra F J.
In-vivo effect of nicotine on
cytokine production by human non-adherent mononuclear cells.
Eur
J Gastroenterol Hepatol.
1996;
8
1017-1020
MissingFormLabel
- 18
Van Dijk A P, Meijssen M A, Brouwer A J, Hop W C, van
Bergeijk J D, Feyerabend C, Wilson J H, Zijlstra F J.
Transdermal nicotine inhibits interleukin
2 synthesis by mononuclear cells derived from healthy volunteers.
Eur
J Clin Invest.
1998;
28
664-671
MissingFormLabel
- 19
Motley R J, Rhodes J, Williams G, Tavares I A, Bennett A.
Smoking,
eicosanoids and ulcerative colitis.
J Pharm Pharmacol.
1990;
42
288-289
MissingFormLabel
- 20
Zijlstra F J, Srivastava E D, Rhodes M, van Dijk A P, Fogg F, Samson H J, Copeman M, Russell M A, Feyerabend C, Williams G T. et
al .
Effect of nicotine on rectal mucus and mucosal
eicosanoids.
Gut.
1994;
35
247-251
MissingFormLabel
- 21
Lashner B A, Hanauer S B, Silverstein M D.
Testing nicotine gum for ulcerative
colitis patients. Experience with single-patient trials.
Dig
Dis Sci.
1990;
35
827-832
MissingFormLabel
- 22
Pullan R D, Rhodes J, Ganesh S, Mani V, Morris J S, Williams G T, Newcombe R G, Russell M A, Feyerabend C, Thomas G A. et
al .
Transdermal nicotine for active ulcerative colitis.
N
Engl J Med.
1994;
330
811-815
MissingFormLabel
- 23
Thomas G A, Rhodes J, Mani V, Williams G T, Newcombe R G, Russell M A, Feyerabend C.
Transdermal nicotine as maintenance therapy
for ulcerative colitis.
N Engl J Med.
1995;
332
988-992
MissingFormLabel
- 24
Thomas G A, Rhodes J, Ragunath K, Mani V, Williams G T, Newcombe R G, Russell M A, Feyerabend C.
Transdermal
nicotine compared with oral prednisolone therapy for active ulcerative
colitis.
Eur J Gastroenterol Hepatol.
1996;
8
769-776
MissingFormLabel
- 25
Sandborn W J, Tremaine W J, Offord K P, Lawson G M, Petersen B T, Batts K P, Croghan I T, Dale L C, Schroeder D R, Hurt R D.
Transdermal nicotine for mildly
to moderately active ulcerative colitis. A randomized, double-blind,
placebo-controlled trial.
Ann Intern Med.
1997;
126
364-371
MissingFormLabel
- 26
Guslandi M, Tittobello A.
Outcome of ulcerative
colitis after treatment with transdermal nicotine.
Eur
J Gastroenterol Hepatol.
1998;
10
513-515
MissingFormLabel
- 27
Konsensuskonferenz der
DGVS.
Diagnostik und Therapie der Colitis ulcerosa.
Z
Gastroenterol.
2001;
39
19-70
MissingFormLabel
Autoren
Dr. C. G. Dietrich
PD Dr. F. Lammert
Prof. Dr. S Matern
Medizinische
Klinik III, Universitätsklinikum der RWTH
Pauwelsstr.
30
52074 Aachen